p.127 抽出テキスト

JAMA 2004; 292: 1307–1316. PMID: 15337732 573. Cannon CP, Braunwald E, McCabe CH, et al. Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004; 350: 1495–1504. PMID: 15007110 574. Schwartz GG, Olsson AG, Ezekowitz MD, et al. Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 2001; 285: 1711–1718. PMID: 11277825 575. Gencer B, Nanchen D. Identifying familial hypercholesterolemia in acute coronary syndrome. Curr Opin Lipidol 2016; 27: 375–381. PMID: 27092769 576. Ohmura H, Fukushima Y, Mizuno A, et al. Research Committee on Primary Hyperlipidemia of the Ministry of Health and Welfare of Japan. Estimated Prevalence of Heterozygous Familial Hypercholesterolemia in Patients With Acute Coronary Syndrome. Int Heart J 2017; 58: 88–94. PMID: 28123161 577. Rosenson RS. Myocardial injury: the acute phase response and lipoprotein metabolism. J Am Coll Cardiol 1993; 22: 933–940. PMID: 7689082 578. Lee KH, Jeong MH, Kim HM, et al. KAMIR (Korea Acute Myocardial Infarction Registry) Investigators. Benefit of early statin therapy in patients with acute myocardial infarction who have extremely low low-density lipoprotein cholesterol. J Am Coll Cardiol 2011; 58: 1664–1671. PMID: 21982310 579. Sjauw KD, Engström AE, Vis MM, et al. A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? Eur Heart J 2009; 30: 459–468. PMID: 19168529 580. Thiele H, Zeymer U, Neumann FJ, et al. IABP-SHOCK II Trial Investigators. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 2012; 367: 1287–1296. PMID: 22920912 581. Patel MR, Smalling RW, Thiele H, et al. Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: the CRISP AMI randomized trial. JAMA 2011; 306: 1329–1337. PMID: 21878431 582. Scheidt S, Wilner G, Mueller H, et al. Intra-aortic balloon counterpulsation in cardiogenic shock. Report of a co-operative clinical trial. N Engl J Med 1973; 288: 979–984. PMID: 4696253 583. De Silva K, Lumley M, Kailey B, et al. Coronary and microvascular physiology during intra-aortic balloon counterpulsation. JACC Cardiovasc Interv 2014; 7: 631–640. PMID: 24726295 584. Ahmad Y, Sen S, Shun-Shin MJ, et al. Intra-aortic Balloon Pump Therapy for Acute Myocardial Infarction: A Meta-analysis. JAMA Intern Med 2015; 175: 931–939. PMID: 25822657 585. van Nunen LX, van ‘t Veer M, Schampaert S, et al. Intra-aortic balloon counterpulsation reduces mortality in large anterior myocardial infarction complicated by persistent ischaemia: a CRISP-AMI substudy. EuroIntervention 2015; 11: 286–292. PMID: 25254356 586. Inohara T, Miyata H, Ueda I, et al. Use of Intra-aortic Balloon Pump in a Japanese Multicenter Percutaneous Coronary Intervention Registry. JAMA Intern Med 2015; 175: 1980–1982. PMID: 26523549 587. Sandhu A, McCoy LA, Negi SI, et al. Use of mechanical circulatory support in patients undergoing percutaneous coronary intervention: insights from the National Cardiovascular Data Registry. Circulation 2015; 132: 1243–1251. PMID: 26286905 588. Basir MB, Schreiber T, Dixon S, et al. Feasibility of early mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock: The Detroit cardiogenic shock initiative. Catheter Cardiovasc Interv 2018; 91: 454–461. PMID: 29266676 589. Thiele H, Jobs A, Ouweneel DM, et al. Percutaneous short-term active mechanical support devices in cardiogenic shock: a systematic review and collaborative meta-analysis of randomized trials. Eur Heart J 2017; 38: 3523–3531. PMID: 29020341 590. Ouweneel DM, Eriksen E, Sjauw KD, et al. Percutaneous Mechanical Circulatory Support Versus Intra-Aortic Balloon Pump in Cardiogenic Shock After Acute Myocardial Infarction. J Am Coll Cardiol 2017; 69: 278–287. PMID: 27810347 591. Yonezu K, Sakakura K, Watanabe Y, et al. Determinants of survival and favorable neurologic outcomes in ischemic heart disease treated by veno-arterial extracorporeal membrane oxygenation. Heart Vessels 2018; 33: 25–32. PMID: 28776067 592. Aiba T, Nonogi H, Itoh T, et al. Appropriate indications for the use

of a percutaneous cardiopulmonary support system in cases with cardiogenic shock complicating acute myocardial infarction. Jpn Circ J 2001; 65: 145–149. PMID: 11266185 593. Okada H, Nishida M, Murakami M, et al. Surgical treatment for

complications of acute myocardial infarction. Jpn J Thorac Cardiovasc Surg 2005; 53: 74–77. PMID: 15782567 594. 第2 章成人の二次救命処置.日本蘇生協議会監修.JRC 蘇生ガイドライン2015.医学書院 2016: 43–174. 595. Shah M, Patnaik S, Patel B, et al. Trends in mechanical circulatory support use and hospital mortality among patients with acute myocardial infarction and non-infarction related cardiogenic shock in the United States. Clin Res Cardiol 2018; 107: 287–303. PMID: 29134345 596. 日本経皮的心肺補助研究会.PCPS 研究会アンケート集計結果http://www2.convention.co.jp/pcps/pdf/enquete.pdf 597. Nagao K, Kikushima K, Watanabe K, et al. Early induction of hypothermia during cardiac arrest improves neurological outcomes in patients with out-of-hospital cardiac arrest who undergo emergency cardiopulmonary bypass and percutaneous coronary intervention. Circ J 2010; 74: 77–85. PMID: 19942784 598. Garan AR, Eckhardt C, Takeda K, et al. Predictors of survival and ability to wean from short-term mechanical circulatory support device following acute myocardial infarction complicated by cardiogenic shock. Eur Heart J Acute Cardiovasc Care 2018; 7: 755–765. PMID: 29094607 599. Mitsui N, Koyama T, Marui A, et al. Experience with emergency cardiac surgery following institution of percutaneous cardiopulmonary support. Artif Organs 1999; 23: 496–499. PMID: 10392272 600. Sakamoto T, Morimura N, Nagao K, et al. SAVE-J Study Group. Extracorporeal cardiopulmonary resuscitation versus conventional cardiopulmonary resuscitation in adults with out-of-hospital cardiac arrest: a prospective observational study. Resuscitation 2014; 85: 762–768. PMID: 24530251 601. Kagawa E, Dote K, Kato M, et al. Should we emergently revascularize occluded coronaries for cardiac arrest?: rapid-response extracorporeal membrane oxygenation and intra-arrest percutaneous coronary intervention. Circulation 2012; 126: 1605–1613. PMID: 22899771 602. Kuroki N, Abe D, Iwama T, et al. Association between delay to coronary reperfusion and outcome in patients with acute coronary syndrome undergoing extracorporeal cardiopulmonary resuscitation. Resuscitation 2017; 114: 1–6. PMID: 28215592 603. Morisawa D, Higuchi Y, Iwakura K, et al. Predictive factors for successful weaning from percutaneous cardiopulmonary support in patients with cardiogenic shock complicating acute myocardial infarction. J Cardiol 2012; 60: 350–354. PMID: 22819038 604. Oshima K, Morishita Y, Hinohara H, et al. Factors for weaning from a percutaneous cardiopulmonary support system (PCPS) in patients with severe cardiac failure: a comparative study in weaned and nonweaned patients. Int Heart J 2006; 47: 575–584. PMID: 16960412 605. Yamauchi T, Masai T, Takeda K, et al. Percutaneous cardiopulmonary support after acute myocardial infarction at the left main trunk. Ann Thorac Cardiovasc Surg 2009; 15: 93–7. PMID: 19471222 606. 日本循環器学会,日本心臓血管外科学会.循環器病の診断と治療に関するガイドライン2013:重症心不全に対する植込型補助人工心臓治療ガイドライン.http://www.j-circ.or.jp/guideline/pdf/ JCS2013_kyo_h.pdf 607. Priori SG, Blomström-Lundqvist C, Mazzanti A, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 2015; 36: 2793–2867. PMID: 26320108 608. Zafari AM, Zarter SK, Heggen V, et al. A program encouraging early defibrillation results in improved in-hospital resuscitation efficacy. J Am Coll Cardiol 2004; 44: 846–852. PMID: 15312869 609. Dorian P, Cass D, Schwartz B, et al. Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation. N Engl J Med 2002; 346: 884–890. PMID: 11907287 610. Kudenchuk PJ, Cobb LA, Copass MK, et al. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med 1999; 341: 871–878. PMID: 10486418 611. Ando J, Kakishita M, Sakai K, et al. Efficacy of nifekalant hydrochloride in the treatment of fatal ventricular arrhythmia in patients with ischemic heart disease. Int Heart J 2005; 46: 647–656. PMID: 16157956 612. Katoh T, Mitamura H, Matsuda N, et al. Emergency treatment with

nifekalant, a novel class III anti-arrhythmic agent, for life-threatening refractory ventricular tachyarrhythmias: post-marketing special